GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Prestige Consumer Healthcare Inc (FRA:PBV) » Definitions » Shiller PE Ratio

Prestige Consumer Healthcare (FRA:PBV) Shiller PE Ratio : 27.59 (As of May. 01, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Prestige Consumer Healthcare Shiller PE Ratio?

As of today (2024-05-01), Prestige Consumer Healthcare's current share price is €66.50. Prestige Consumer Healthcare's E10 for the quarter that ended in Dec. 2023 was €2.41. Prestige Consumer Healthcare's Shiller PE Ratio for today is 27.59.

The historical rank and industry rank for Prestige Consumer Healthcare's Shiller PE Ratio or its related term are showing as below:

FRA:PBV' s Shiller PE Ratio Range Over the Past 10 Years
Min: 16.35   Med: 26.95   Max: 300
Current: 26.99

During the past years, Prestige Consumer Healthcare's highest Shiller PE Ratio was 300.00. The lowest was 16.35. And the median was 26.95.

FRA:PBV's Shiller PE Ratio is ranked worse than
54.03% of 533 companies
in the Drug Manufacturers industry
Industry Median: 24.9 vs FRA:PBV: 26.99

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Prestige Consumer Healthcare's adjusted earnings per share data for the three months ended in Dec. 2023 was €0.972. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is €2.41 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Prestige Consumer Healthcare Shiller PE Ratio Historical Data

The historical data trend for Prestige Consumer Healthcare's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prestige Consumer Healthcare Shiller PE Ratio Chart

Prestige Consumer Healthcare Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.24 19.58 20.14 20.05 25.64

Prestige Consumer Healthcare Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.41 25.64 23.56 22.26 23.03

Competitive Comparison of Prestige Consumer Healthcare's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Prestige Consumer Healthcare's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Prestige Consumer Healthcare's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Prestige Consumer Healthcare's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Prestige Consumer Healthcare's Shiller PE Ratio falls into.



Prestige Consumer Healthcare Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Prestige Consumer Healthcare's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=66.50/2.41
=27.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prestige Consumer Healthcare's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Prestige Consumer Healthcare's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.972/129.4194*129.4194
=0.972

Current CPI (Dec. 2023) = 129.4194.

Prestige Consumer Healthcare Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 0.217 99.695 0.282
201406 0.236 100.560 0.304
201409 0.241 100.428 0.311
201412 0.324 99.070 0.423
201503 0.416 99.621 0.540
201506 0.437 100.684 0.562
201509 0.535 100.392 0.690
201512 0.487 99.792 0.632
201603 0.233 100.470 0.300
201606 -0.089 101.688 -0.113
201609 0.535 101.861 0.680
201612 0.559 101.863 0.710
201703 0.196 102.862 0.247
201706 0.561 103.349 0.703
201709 0.478 104.136 0.594
201712 4.969 104.011 6.183
201803 -0.608 105.290 -0.747
201806 0.556 106.317 0.677
201809 0.506 106.507 0.615
201812 0.642 105.998 0.784
201903 -2.372 107.251 -2.862
201906 0.575 108.070 0.689
201909 0.590 108.329 0.705
201912 0.675 108.420 0.806
202003 0.661 108.902 0.786
202006 0.764 108.767 0.909
202009 0.747 109.815 0.880
202012 0.666 109.897 0.784
202103 0.588 111.754 0.681
202106 0.946 114.631 1.068
202109 0.757 115.734 0.847
202112 0.876 117.630 0.964
202203 0.926 121.301 0.988
202206 1.031 125.017 1.067
202209 1.030 125.227 1.064
202212 0.982 125.222 1.015
202303 -4.511 127.348 -4.584
202306 0.978 128.729 0.983
202309 1.003 129.860 1.000
202312 0.972 129.419 0.972

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Prestige Consumer Healthcare  (FRA:PBV) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Prestige Consumer Healthcare Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Prestige Consumer Healthcare's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Prestige Consumer Healthcare (FRA:PBV) Business Description

Traded in Other Exchanges
Address
660 White Plains Road, Tarrytown, NY, USA, 10591
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Prestige Consumer Healthcare (FRA:PBV) Headlines

No Headlines